Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2005 Aug;97(8):1161–1164.

Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy.

Mustafa Baydar 1, Mustafa Dikilitas 1, Alper Sevinc 1, Ismet Aydogdu 1
PMCID: PMC2575965  PMID: 16173332

Abstract

INTRODUCTION: One of the most common and important side effects of 5-fluorouracil (5-FU) is mucositis with ulcerations in the oral cavity. We investigated the effects of local cryotherapy on mucositis incidence administrated durng 5-FU treatment. METHODS: In a total of 99 courses, 5-FU and folinic acid combination chemotherapy was given to 40 patients. In our study, we considered every course as a single case, and cryotherapy was given to the same patient in one course but not given in the next. RESULTS: While mucositis developed in 6.7% of the courses given with cryotherapy, this ratio was 38.9% in courses given without cryotherapy. In the logistic regression analysis, development of mucositis had been found to correlate only with cryotherapy. Odds ratio (OR) = 11.5; in the 95% confidence interval (CI) = 3.2 - 41.9; (p = 0.001). DISCUSSION: Results of initial studies evaluating the effects of cryotherapy in preventing mucositis due to 5-FU based chemotherapy regimens were promising. We concluded that oral cooling prevents 5-FU induced mucositis. This effective prophylactic treatment should be used in patients who are at increased risk for developing 5-FU induced mucositis.

Full text

PDF
1164

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger A., Henderson M., Nadoolman W., Duffy V., Cooper D., Saberski L., Bartoshuk L. Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy. J Pain Symptom Manage. 1995 Apr;10(3):243–248. doi: 10.1016/0885-3924(94)00130-D. [DOI] [PubMed] [Google Scholar]
  2. Chi K. H., Chen C. H., Chan W. K., Chow K. C., Chen S. Y., Yen S. H., Chao J. Y., Chang C. Y., Chen K. Y. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol. 1995 Oct;13(10):2620–2628. doi: 10.1200/JCO.1995.13.10.2620. [DOI] [PubMed] [Google Scholar]
  3. Dodd M. J., Larson P. J., Dibble S. L., Miaskowski C., Greenspan D., MacPhail L., Hauck W. W., Paul S. M., Ignoffo R., Shiba G. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum. 1996 Jul;23(6):921–927. [PubMed] [Google Scholar]
  4. Fidler P., Loprinzi C. L., O'Fallon J. R., Leitch J. M., Lee J. K., Hayes D. L., Novotny P., Clemens-Schutjer D., Bartel J., Michalak J. C. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer. 1996 Feb 1;77(3):522–525. doi: 10.1002/(SICI)1097-0142(19960201)77:3<522::AID-CNCR14>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  5. Johansson C., Bergström S. Prostaglandin and protection of the gastroduodenal mucosa. Scand J Gastroenterol Suppl. 1982;77:21–46. [PubMed] [Google Scholar]
  6. Labar B., Mrsić M., Pavletić Z., Bogdanić V., Nemet D., Aurer I., Radman I., Filipović-Grcić N., Sertić D., Kalenić S. Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transplant. 1993 May;11(5):379–382. [PubMed] [Google Scholar]
  7. Loprinzi C. L., Cianflone S. G., Dose A. M., Etzell P. S., Burnham N. L., Therneau T. M., Hagen L., Gainey D. K., Cross M., Athmann L. M. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer. 1990 Apr 15;65(8):1879–1882. doi: 10.1002/1097-0142(19900415)65:8<1879::aid-cncr2820650834>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  8. Loprinzi C. L., Ghosh C., Camoriano J., Sloan J., Steen P. D., Michalak J. C., Schaefer P. L., Novotny P. J., Gerstner J. B., White D. F. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol. 1997 Mar;15(3):1235–1238. doi: 10.1200/JCO.1997.15.3.1235. [DOI] [PubMed] [Google Scholar]
  9. Mahood D. J., Dose A. M., Loprinzi C. L., Veeder M. H., Athmann L. M., Therneau T. M., Sorensen J. M., Gainey D. K., Mailliard J. A., Gusa N. L. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol. 1991 Mar;9(3):449–452. doi: 10.1200/JCO.1991.9.3.449. [DOI] [PubMed] [Google Scholar]
  10. Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., Carbone P. P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649–655. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES